183 related articles for article (PubMed ID: 19877888)
1. A (99m)Tc-labeled triphenylphosphonium derivative for the early detection of breast tumors.
Li Z; Lopez M; Hardy M; McAllister DM; Kalyanaraman B; Zhao M
Cancer Biother Radiopharm; 2009 Oct; 24(5):579-87. PubMed ID: 19877888
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
3. The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Arslan N; Ozturk E; Ilgan S; Narin Y; Dundar S; Tufan T; Pekcan M; Bayhan H
Ann Nucl Med; 2000 Feb; 14(1):39-46. PubMed ID: 10770579
[TBL] [Abstract][Full Text] [Related]
4. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
5.
Tesan FC; Nicoud MB; Nuñez M; Medina VA; Chiappetta DA; Salgueiro MJ
Contrast Media Mol Imaging; 2019; 2019():4087895. PubMed ID: 31178670
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
7. LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.
Sharma S; Singh B; Mishra AK; Rathod D; Hazari PP; Chuttani K; Chopra S; Singh PM; Abrar ML; Mittal BR; Singh G
Cancer Biother Radiopharm; 2014 Sep; 29(7):283-8. PubMed ID: 25203145
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic evolution of a breast cancer with Tc-99m MIBI scintimammography.
Mateos JJ; Vidal S; Muñoz M; Fuster D; Martin F; Ortega M; Pons F
Clin Nucl Med; 2000 Sep; 25(9):701-3. PubMed ID: 10983758
[TBL] [Abstract][Full Text] [Related]
9. [In vivo imaging of breast tumors by a
Kang L; Huo Y; Wang RF; Zhang CL; Yan P; Xu XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):326-330. PubMed ID: 29643534
[TBL] [Abstract][Full Text] [Related]
10. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Sohaib M; Afshan A; Saeed S; Khalid MA; Yousuf M
Pak J Pharm Sci; 2014 Sep; 27(5):1287-94. PubMed ID: 25176364
[TBL] [Abstract][Full Text] [Related]
12. [Development of radiopharmaceuticals for diagnosis and therapy of metastatic bone cancer].
Ogawa K
Yakugaku Zasshi; 2012; 132(10):1151-7. PubMed ID: 23037700
[TBL] [Abstract][Full Text] [Related]
13. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
14. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.
Wang HC; Sun SS; Kao A; Lin CC; Lee CC
Cancer Invest; 2002; 20(3):318-23. PubMed ID: 12025226
[TBL] [Abstract][Full Text] [Related]
15. Physiological fluctuation of (99m)Tc-sestamibi uptake in normal mammary glands: a systematic investigation in female rats.
Larson M; Larson M; Li Z; Larson M; Li Z; Hall CL; Jensen E; McAllister DM; Kalyanaraman B; Zhao M
Acta Radiol; 2009 Nov; 50(9):975-8. PubMed ID: 19863405
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Palmedo H; Hensel J; Reinhardt M; Von Mallek D; Matthies A; Biersack HJ
Nucl Med Biol; 2002 Nov; 29(8):809-15. PubMed ID: 12453590
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of the quantification of (99M)Tc-MIBI uptake in breast neoplasms in the preoperative assessment of tumor aggressiveness].
Mulero F; Nicolás F; Roca V; Castellón MA; Claver MA; de La Cruz P; Abad L; Nuño De La Rosa JA
Rev Esp Med Nucl; 2000 Aug; 19(4):263-9. PubMed ID: 11062096
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Bekiş R; Degirmenci B; Aydin A; Ozdogan O; Canda T; Durak H
Nucl Med Biol; 2005 Jul; 32(5):465-72. PubMed ID: 15982577
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
20. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging.
Derebek E; Balci P; Alanyali H; Kocdor MA; Capa G; Gorken IB; Degirmenci B; Alakavuklar M; Canda T; Durak H
Clin Nucl Med; 1999 Aug; 24(8):590-3. PubMed ID: 10439180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
